Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy

Mesenchymal stem cells (MSCs) are a promising cellular vehicle for transferring anti-cancer factors to malignant tumors. Currently, a variety of anti-cancer agents, including the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), have been loaded into MSCs derived from a range of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zujia, Chen, Hongting, Wang, Peiyun, Zhou, Miaojin, Li, Guangxu, Hu, Zhiqing, Hu, Qian, Zhao, Junya, Liu, Xionghao, Wu, Lingqian, Liang, Desheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cell-Based Drug Development, Screening, and Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968737/
https://www.ncbi.nlm.nih.gov/pubmed/35267023
http://dx.doi.org/10.1093/stcltm/szab031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968737/
https://www.ncbi.nlm.nih.gov/pubmed/35267023
http://dx.doi.org/10.1093/stcltm/szab031

Ejemplares similares